Kangmei Pharmaceutical Co Ltd (600518) — Cash Flow Reinvestment Rate
Kangmei Pharmaceutical Co Ltd (600518) has a Cash Flow Reinvestment Rate of 0.22x as of September 2025, reinvesting CN¥48.57 Million (capex CN¥48.57 Million ) from operating cash flow of CN¥219.96 Million. Check 600518 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kangmei Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2021)
Historical reinvestment intensity for Kangmei Pharmaceutical Co Ltd across 22 annual periods. Explore Kangmei Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Kangmei Pharmaceutical Co Ltd (1999–2021)
Year-by-year capital reinvestment analysis for Kangmei Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 600518 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.80x | CN¥171.64 Million | CN¥214.21 Million | CN¥171.63 Million | ▲ +173.9% |
| 2020 | 0.29x | CN¥301.74 Million | CN¥1.03 Billion | CN¥301.73 Million | ▲ +7.2% |
| 2019 | 0.27x | CN¥786.25 Million | CN¥2.88 Billion | CN¥473.20 Million | ▼ -98.2% |
| 2018 | 15.06x | CN¥4.60 Billion | CN¥305.62 Million | CN¥4.59 Billion | ▲ +1429.0% |
| 2016 | 0.99x | CN¥1.58 Billion | CN¥1.60 Billion | CN¥1.57 Billion | ▼ -63.8% |
| 2015 | 2.73x | CN¥1.39 Billion | CN¥508.86 Million | CN¥1.37 Billion | ▲ +352.4% |
| 2014 | 0.60x | CN¥682.06 Million | CN¥1.13 Billion | CN¥682.06 Million | ▲ +43.4% |
| 2013 | 0.42x | CN¥703.43 Million | CN¥1.67 Billion | CN¥703.43 Million | ▼ -69.8% |
| 2012 | 1.39x | CN¥1.41 Billion | CN¥1.01 Billion | CN¥1.41 Billion | ▼ -65.5% |
| 2011 | 4.04x | CN¥2.32 Billion | CN¥574.96 Million | CN¥2.32 Billion | ▲ +251.7% |
| 2010 | 1.15x | CN¥768.02 Million | CN¥669.19 Million | CN¥768.02 Million | ▼ -81.1% |
| 2009 | 6.06x | CN¥724.25 Million | CN¥119.47 Million | CN¥724.25 Million | ▼ -97.4% |
| 2008 | 229.90x | CN¥693.14 Million | CN¥3.02 Million | CN¥693.14 Million | ▲ +11285.6% |
| 2007 | 2.02x | CN¥328.23 Million | CN¥162.55 Million | CN¥328.23 Million | ▼ -66.6% |
| 2006 | 6.05x | CN¥413.45 Million | CN¥68.32 Million | CN¥413.45 Million | ▲ +3496.3% |
| 2005 | 0.17x | CN¥22.40 Million | CN¥133.13 Million | CN¥22.40 Million | ▼ -91.2% |
| 2004 | 1.91x | CN¥150.20 Million | CN¥78.52 Million | CN¥150.20 Million | ▲ +206.9% |
| 2003 | 0.62x | CN¥48.63 Million | CN¥78.02 Million | CN¥48.63 Million | ▼ -83.5% |
| 2002 | 3.79x | CN¥202.41 Million | CN¥53.47 Million | CN¥202.41 Million | ▼ -49.0% |
| 2001 | 7.43x | CN¥116.54 Million | CN¥15.69 Million | CN¥116.54 Million | ▲ +4442.5% |
| 2000 | 0.16x | CN¥1.63 Million | CN¥9.96 Million | CN¥1.63 Million | ▼ -61.8% |
| 1999 | 0.43x | CN¥12.96 Million | CN¥30.25 Million | CN¥12.96 Million | — |